Craft
  • Home
  •  / Thermo Fisher Scientific
Thermo Fisher Scientific

Thermo Fisher Scientific

Remaining Performance Obligations

$26.6 B

Q3, 2023

Revenue

$39.2 B

FY, 2021

Market Capitalization

$230.1 B

2023-01-13

Thermo Fisher Scientific Summary

Company summary

Overview
Thermo Fisher Scientific is a global provider of laboratory products and services, life science solutions, analytical instruments, and specialty diagnostics. It offers reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of disease, instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field, diagnostic test kits, reagents, culture media, instruments, and associated products, self-manufactured and sourced products as well as outsourced services used by the pharmaceutical and biotech industries for drug development, clinical trial logistics, and commercial drug manufacturing.
Type
Public
Status
Active
Founded
1956
HQ
Waltham, MA, US | view all locations
Website
https://www.thermofisher.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key people

  • Marc N. Casper

    Marc N. Casper, Chairman, President and Chief Executive Officer

  • Stephen Williamson

    Stephen Williamson, Senior Vice President and Chief Financial Officer

  • Sandy Pound

    Sandy Pound, Vice President and Chief Communications Officer

  • Karen E. Nelson

    Karen E. Nelson, Chief Scientific Officer

Operating MetricsView all

Customers

400K

FY, 2020

Backlog (Laboratory Products and Services)

$4.6B

FY, 2019

Backlog

$7.8B

FY, 2019

LocationsView all

441 locations detected

  • Waltham, MA HQ

    United States

    168 3rd Ave

  • Agawam, MA

    United States

    325 Bowles Rd

  • Allentown, PA

    United States

    7554 Schantz Road

  • Ann Arbor, MI

    United States

    110 Miller Ave

  • Asheville, NC

    United States

    275 Aiken Rd

  • Auburn, AL

    United States

    2039 McMillan Street

and 435 others

Thermo Fisher Scientific Financials

Summary financials

Revenue (Q3, 2022)
$10.7B
Gross profit (Q3, 2022)
$4.3B
Net income (Q3, 2022)
$1.5B
Cash (Q3, 2022)
$2.9B
EBIT (Q3, 2022)
$1.7B
Enterprise value
$256.3B

Footer menu